Implications of AB0 blood group in hypertensive patients with covid-19
Abstract Background Hypertension is the most frequent co-morbidity in patients with covid-19 infection, and we might speculate that a specific blood group could play a key role in the clinical outcome of hypertensive patients with covid-19. Methods In this prospective study, we compared 0 vs. non-0...
Main Authors: | Celestino Sardu, Raffaele Marfella, Paolo Maggi, Vincenzo Messina, Paolo Cirillo, Vinicio Codella, Jessica Gambardella, Antonio Sardu, Gianluca Gatta, Gaetano Santulli, Giuseppe Paolisso |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Cardiovascular Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12872-020-01658-z |
Similar Items
-
Could Anti‐Hypertensive Drug Therapy Affect the Clinical Prognosis of Hypertensive Patients With COVID‐19 Infection? Data From Centers of Southern Italy
by: Celestino Sardu, et al.
Published: (2020-09-01) -
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
by: Celestino Sardu, et al.
Published: (2020-05-01) -
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up
by: Celestino Sardu, et al.
Published: (2021-11-01) -
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
by: Celestino Sardu, et al.
Published: (2020-06-01) -
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
by: Alessandro Matarese, et al.
Published: (2020-10-01)